[ET Net News Agency, 27 February 2025] INNOCARE (09969) rose 10.5% to HK$9.9.
It hits an intra-day high of HK$9.94, hitting a 52-week high, and an intra-day low of
HK$8.9. The total shares traded was 34.21 million, with a value of HK$320.48m. The active
buy/sell ratio is 63:37, with net buying turnover of HK$76.41m. HSBC SEC BRO (ASIA)
accounts for greatest net responsive buying turnover of HK$15.5m, with volume weighted
average price of HK$9.437. MORGAN STANLEY HK SEC accounts for greatest net responsive
selling turnover of HK$20.77m, with volume weighted average price of HK$9.417. The stock
has risen a combined 52.3% over the past 8 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 9.900 % Chg +10.49%
High 9.940 Low 8.900
Shares Tr 34.21m Turnover 320.48m
10-D SMA 7.696 %H.V 76.943
20-D SMA 6.682 VWAP 9.367
50-D SMA 6.105 RSI14 89.597
----------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 63:37, with net buying turnover
of HK$76.41m, rising a combined 52.3% over the past 8 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
INNOCARE (09969) 9.90 +10.49
HUTCHMED (00013) 26.70 +2.30
GENSCRIPT BIO (01548) 13.08 -3.54
INNOVENT BIO (01801) 42.95 -0.23
EVEREST MED-B (01952) 47.30 -1.46
CARSGEN-B (02171) 16.84 +0.24
WUXI BIO (02269) 23.55 -0.84
WUXI APPTEC (02359) 62.40 -1.42
BEIGENE (06160) 160.40 -0.74
AKESO (09926) 74.90 +1.49
---------------------------------------------
(ed)